Michael P. Murphy

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.